Kovaxin: India develops Kovid vaccine with 81% effectiveness

Kovaxin: India develops Kovid vaccine with 81% effectiveness

Indian pharmaceutical laboratory Bharat Biotech reported that the test results showed that vaccination is effective against variants of coronovirus

The Indian pharmaceutical laboratory Bharat Biotech told Wednesday (3) that its vaccine “Kovaxin”, highly criticized for being launched before the final tests, reached an efficiency of about 81% in prevention against Kovid-19.

The effectiveness of Bharat Biotech’s “Kovaxin” raised questions from medical staff after it was authorized by authorities on an emergency basis in January, although its Phase 3 trials in the final phase before the final phase are yet to be completed.

“Kovaxin (not only) exhibits a trend towards high clinical efficacy against Kovid-19, but also significant immunogenicity (the ability to induce an antigen) against unexpectedly arising variants.” Said Krishna Ella, president of Bharat Biotech.

The company stated that “serious adverse effects, requiring medical assistance, were at very low levels and were balanced between vaccine and place groups.”

Kovacsin, along with Kovishield from AstraZeneca / Oxford, manufactured in India, are the two authorized vaccines in the country.

The lack of data on covaxin, when the vaccination campaign began in mid-January, aroused suspicion, as members of health workers, including doctors, refused to vaccinate.

Prime Minister Narendra Modi received a dose of Kovaxin on Monday, when the vaccine was extended to more than 60 people and more than 45 critical conditions.

abh / grk / st / age / mb / mr

In times of disintegration and epidemic, the newspaper Time Strengthens the commitment to quality, professionalism and Minas Gerais journalism. Our newsroom produces responsible and reliable information every day. Keep supporting us. Please sign on time.

READ  Arkansas sheriff resigns more than racist rant in leaked recording

Cory Weinberg

About the author: Cory Weinberg

Cory Weinberg covers the intersection of tech and cities. That means digging into how startups and big tech companies are trying to reshape real estate, transportation, urban planning, and travel. Previously, he reported on Bay Area housing and commercial real estate for the San Francisco Business Times. He received a "best young journalist" award from the National Association of Real Estate Editors.

Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *